SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-042017
Filing Date
2019-11-08
Accepted
2019-11-08 08:01:26
Documents
58
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q arct-10q_20190930.htm 10-Q 1601009
2 EX-10.25 arct-ex1025_85.htm EX-10.25 44645
3 EX-31.1 arct-ex311_7.htm EX-31.1 18796
4 EX-31.2 arct-ex312_10.htm EX-31.2 18752
5 EX-32.1 arct-ex321_12.htm EX-32.1 8120
6 EX-32.2 arct-ex322_6.htm EX-32.2 8052
  Complete submission text file 0001564590-19-042017.txt   5380893

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT arct-20190930.xml EX-101.INS 863238
8 XBRL TAXONOMY EXTENSION SCHEMA arct-20190930.xsd EX-101.SCH 55638
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arct-20190930_cal.xml EX-101.CAL 40628
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arct-20190930_def.xml EX-101.DEF 176744
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE arct-20190930_lab.xml EX-101.LAB 387210
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arct-20190930_pre.xml EX-101.PRE 294853
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Filer) CIK: 0001768224 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38942 | Film No.: 191202142
SIC: 2834 Pharmaceutical Preparations